BUZZ-Inovio Pharma shares fall due to planned stock offering

November 5 - ** As it seeks financing, Inovio Pharmaceuticals INO.O shares dropped 22.1% in after-hours trading to $1.13

** The biotechnology company announced a (link) public offering of stock, but did not disclose the size of the transaction

** Jefferies and Piper Sandler are acting as joint book-running managers

** On Monday, after the U.S. Food and Drug Administration (FDA) approved (link) the company's drug Voceryq for the treatment of a rare throat disease, INO shares more than tripled to close at $1.89

** According to the prospectus, as of September 30, INO, headquartered in Plymouth Meeting, Pennsylvania, had approximately 110.2 million shares outstanding (link)

** On Thursday, INO shares closed down 10.5% at $1.45

(To facilitate non-native English speakers, Reuters provides automated translations of its reports into several other languages. As automated translation may be inaccurate or lack necessary context, Reuters does not guarantee the accuracy of the translated text, which is provided for reader convenience only. Reuters is not liable for any damages or losses resulting from the use of this automated translation feature.)